Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
190.5 USD | -0.85% | -6.46% | -26.37% |
Apr. 17 | UBS Adjusts Biogen's Price Target to $214 From $250, Maintains Neutral Rating | MT |
Apr. 17 | Wedbush Cuts Biogen's Price Target to $213 From $245 | MT |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.